NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three CountriesGlobeNewsWire · 8 hr ago
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts ContinueGlobeNewsWire · 3 days ago
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the SpotlightGlobeNewsWire · 4 days ago
NeOnc Technologies to Be Featured on Health Uncensored with Dr. Drew to Discuss Reaching Brain Tumors Without Surgery or Systemic ChemotherapyGlobeNewsWire · 4 days ago
NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting ApproachesNewsfile Corp · 5 days ago
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves ForwardGlobeNewsWire · 5 days agoNeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 10, 2026 | -$0.12 | -$0.58 | Miss |
| May 18, 2026 | -$0.22 | -$0.38 | Miss |
| Mar 31, 2026 | -$0.37 | -$0.40 | Miss |
| Nov 14, 2025 | -$0.37 | -$0.45 | Miss |
| Aug 18, 2025 | – | -$0.30 | |
| May 9, 2025 | – | -$2.10 |